YCMGA
EDIT icon

York Capital Management Global Advisors’s Editas Medicine EDIT Stock Holding History

York Capital Management Global Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-154,407
Closed -$2.59M – 74
2017
Q2 		$2.59M Buy
154,407
+4,407
+3% +$79.4K 0.05% 70
2017
Q1 		$3.35M Buy
+150,000
New +$3.11M 0.08% 68

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

York Capital Management Global Advisors's EDIT Position: Q3 2017 in Review

York Capital Management Global Advisors sold out of Editas Medicine (EDIT) in Q3 2017, closing a stake of 154,407 shares — an estimated $2.59M sold.

York Capital Management Global Advisors first reported a position in EDIT in Q1 2017 and held it in 2 quarters. The position peaked at $3.35M in Q1 2017. 116 funds tracked by Wall St. Rank hold EDIT as of Q3 2017.

  • York Capital Management Global Advisors reported no remaining Editas Medicine position as of Q3 2017 after selling out during the quarter.
  • York Capital Management Global Advisors sold 154,407 Editas Medicine shares in Q3 2017, an estimated $2.59M.
  • York Capital Management Global Advisors first reported a position in Editas Medicine in Q1 2017 and held it in 2 quarters.
  • York Capital Management Global Advisors's Editas Medicine position peaked at $3.35M in Q1 2017.
  • 116 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2017.

Based on York Capital Management Global Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.